313 related articles for article (PubMed ID: 16848106)
1. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
3. Bone mineralization defects after treatment of acute lymphoblastic leukemia ın children.
Guren Dolu M; Canbolat Ayhan A; Erguven M; Timur C; Yoruk A; Ozdemir S
Minerva Pediatr; 2015 Oct; 67(5):419-25. PubMed ID: 26377781
[TBL] [Abstract][Full Text] [Related]
4. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
5. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
6. Reduced bone density at completion of chemotherapy for a malignancy.
Arikoski P; Komulainen J; Riikonen P; Jurvelin JS; Voutilainen R; Kröger H
Arch Dis Child; 1999 Feb; 80(2):143-8. PubMed ID: 10325729
[TBL] [Abstract][Full Text] [Related]
7. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia.
Arikoski P; Komulainen J; Voutilainen R; Riikonen P; Parviainen M; Tapanainen P; Knip M; Kröger H
J Pediatr Hematol Oncol; 1998; 20(3):234-40. PubMed ID: 9628435
[TBL] [Abstract][Full Text] [Related]
8. The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
Vitanza NA; Hogan LE; Zhang G; Parker RI
J Pediatr Hematol Oncol; 2015 Jul; 37(5):356-61. PubMed ID: 25222061
[TBL] [Abstract][Full Text] [Related]
9. [Leptin, body composition and bone mineralization in children after treatment for Wilms tumor].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Konstantynowicz J; Wołczyński S; Siedlecka E
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):53-8. PubMed ID: 15355740
[TBL] [Abstract][Full Text] [Related]
10. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
11. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.
Lequin MH; van der Shuis IM; Van Rijn RR; Hop WC; van ven Huevel-Eibrink MM; MuinckKeizer-Schrama SM; van Kuijk C
J Clin Densitom; 2002; 5(2):167-73. PubMed ID: 12110760
[TBL] [Abstract][Full Text] [Related]
13. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
14. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Łuczyński W; Kaczmarski M; Wołczynski S; Piotrowska-Jastrzebska J
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1041-54. PubMed ID: 15951599
[TBL] [Abstract][Full Text] [Related]
15. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
17. Relative osteopenia after treatment for acute lymphoblastic leukemia.
Warner JT; Evans WD; Webb DK; Bell W; Gregory JW
Pediatr Res; 1999 Apr; 45(4 Pt 1):544-51. PubMed ID: 10203147
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
Thomas IH; Donohue JE; Ness KK; Dengel DR; Baker KS; Gurney JG
Cancer; 2008 Dec; 113(11):3248-56. PubMed ID: 18932250
[TBL] [Abstract][Full Text] [Related]
19. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
[TBL] [Abstract][Full Text] [Related]
20. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
